Denali Therapeutics shares owned by Mercer Global Advisors
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Mercer Global Advisors
from 13F filings
Historical chart of Mercer Global Advisors investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Mercer Global Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-03-31 | $606k | 26k | 23.04 |
| 2022-12-31 | $752k | 27k | 27.82 |
| 2022-09-30 | $804k | 26k | 30.68 |
| 2022-06-30 | $702k | 24k | 29.42 |
| 2022-03-31 | $737k | 23k | 32.16 |
| 2021-12-31 | $774k | 17k | 44.61 |
| 2021-09-30 | $985k | 20k | 50.43 |